A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs PGG-glucan (Primary) ; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 10 Sep 2019 Status changed from active, no longer recruiting to completed.
- 26 May 2019 Planned End Date changed from 1 Aug 2021 to 1 Jul 2019.
- 26 Apr 2019 Status changed from recruiting to active, no longer recruiting.